+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes

  • ID: 4629663
  • Report
  • 65 pages
  • VPA Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Admedus Ltd
  • BlueWillow Biologics
  • Immune Design Corp
  • NanoViricides Inc
  • Rational Vaccines Inc
  • Sanofi Pasteur SA
  • MORE
Genital Herpes Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Genital Herpes Infection pipeline products.

Report Description

The Genital Herpes Infection pipeline guide presents complete overview of drugs currently being developed for Genital Herpes Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Genital Herpes Infection pipeline candidate.

Research and Development progress along with latest news related to each of the Genital Herpes Infection pipeline candidates is included.

Major companies participating in therapeutic development of Genital Herpes Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Genital Herpes Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Genital Herpes Infection clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Genital Herpes Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.

Scope of Genital Herpes Infection pipeline report includes
  • Panorama of Genital Herpes Infection pipeline markets including statistics on therapeutic drugs and companies involved
  • Genital Herpes Infection Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered
  • Genital Herpes Infection pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
  • Overview of companies participating in Genital Herpes Infection pipeline with short introduction to their businesses and pipeline projects
  • For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.
  • Research and Development progress and trial details, results wherever available, are also included in the pipeline study
  • The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Genital Herpes Infection pipeline therapeutics
Reasons to Buy
  • Get clear understanding of the entire Genital Herpes Infection pipeline, with details on active projects
  • Get in detail information of each product with updated information on each project along with key milestones
  • Know the list of companies participating in global Genital Herpes Infection pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
  • Get trial information for each pipeline product under development
  • Understand the pipeline structure in terms of mechanism of Action, phase and company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Admedus Ltd
  • BlueWillow Biologics
  • Immune Design Corp
  • NanoViricides Inc
  • Rational Vaccines Inc
  • Sanofi Pasteur SA
  • MORE
I. Key Findings

1. Companies Investing in Genital Herpes Infection Pipeline include-
Number of Companies with Genital Herpes Infection projects in pre-clinical Development-
Number of Companies with Genital Herpes Infection projects in Clinical Development-
Genital Herpes Infection Pipeline Companies based in Americas
Genital Herpes Infection Pipeline Companies based in Europe
Genital Herpes Infection Pipeline Companies based in Asia Pacific
Genital Herpes Infection Pipeline Companies based in Rest of the World

2. Pipeline Candidates include-
Genital Herpes Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Genital Herpes Infection Pipeline Agents in Clinical Development stage
Genital Herpes Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs-
Small molecules among the Genital Herpes Infection Pipeline agents

II. Insights into Genital Herpes Infection Pipeline -

1. Disease Overview
Introduction to Genital Herpes Infection
Symptoms and Causes of Genital Herpes Infection
Treatment or Prevention Options for Genital Herpes Infection
Other Details
2. Phase wise Pipeline Compounds
Genital Herpes Infection Pipeline- Pre- Clinical/ Discovery stage Drugs
Genital Herpes Infection Pipeline- Phase 1 stage Drugs
Genital Herpes Infection Pipeline- Phase 2 stage Drugs
Genital Herpes Infection Pipeline- Phase 3 stage Drugs
Genital Herpes Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Genital Herpes Infection Pipeline Compounds
4. Genital Herpes Infection Pipeline by Mechanism of Action

III. Genital Herpes Infection Pipeline Compound Details
  • herpes simplex virus vaccine
  • Pritelivir
  • herpes simplex virus-2 vaccines
  • Aspidasept
  • GV2207
  • HDIT101
  • G103
  • ISR-48
  • N-Methanocarbathymidine
  • Drug for Genital Herpes
  • HSV 2 vaccine
  • Profavax HSV vaccine
  • Theravax HSV vaccine
  • HSV-2 vaccine
  • HSV529
  • SPL7013
  • Teg 379
  • UB-621
  • Herpes Simplex Virus 2 vaccine
  • VMTX-004
Drug Details

1. Snapshot-
Name of the Therapeutic Agent
Originator
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Genital Herpes Infection Pipeline Company Briefs
  • Admedus Ltd
  • AiCuris GmbH & Co KG
  • BlueWillow Biologics
  • Brandenburg Antiinfektiva GmbH
  • GenVec Inc
  • Heidelberg ImmunoTherapeutics
  • Immune Design Corp
  • Immune System Regulation Holding AB
  • N & N Pharmaceuticals Inc
  • NanoViricides Inc
  • Profectus BioSciences Inc
  • Rational Vaccines Inc
  • Rational Vaccines Inc
  • Redbiotec AG
  • Sanofi Pasteur SA
  • Starpharma Holdings Ltd
  • TGV-Laboratories
  • United BioPharma
  • Vaccibody
  • Viramatix Sdn Bhd
V. Latest News and Developments in Global Genital Herpes Infection Pipeline Market

VI. Appendix
1. Publisher's Expertise
2. Research Methodology
3. Contact Information

Some of the sections depicted above may be removed or modified on the basis of information availability"
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Admedus Ltd
  • AiCuris GmbH & Co KG
  • BlueWillow Biologics
  • Brandenburg Antiinfektiva GmbH
  • GenVec Inc
  • Heidelberg ImmunoTherapeutics
  • Immune Design Corp
  • Immune System Regulation Holding AB
  • N & N Pharmaceuticals Inc
  • NanoViricides Inc
  • Profectus BioSciences Inc
  • Rational Vaccines Inc
  • Redbiotec AG
  • Sanofi Pasteur SA
  • Starpharma Holdings Ltd
  • TGV-Laboratories
  • United BioPharma
  • Vaccibody
  • Viramatix Sdn Bhd
Note: Product cover images may vary from those shown
Adroll
adroll